We receive many enquiries about participation in our clinical trials. However, we do not accept participants directly through the Small Pharma website or company email addresses. For more information about our clinical trials, please click on the links below. Please note that Small Pharma is not able to diagnose, advise, provide care or make treatment referrals. If you need urgent medical help, please contact the emergency services or your doctor as soon as possible.
Clinical Trial
Location
Status
London, UK
Actively recruiting
SPL026 with supportive therapy Phase IIb in patients with Major Depressive Disorder
Multiple sites (global)
Not recruiting
SPL026 with supportive therapy
Phase I in psychedelic-naive healthy volunteers
London, UK
SPL026 with supportive therapy Phase IIa in patients with Major Depressive Disorder
London & Liverpool, UK
Clinical Trial
Location
Status
SPL026 with supportive therapy Phase IIb in patients with Major Depressive Disorder
Multiple sites (global)
Not recruiting
SPL026 with supportive therapy Phase I in psychedelic-naive healthy volunteers
London, UK
SPL026 with supportive therapy Phase IIa in patients with Major Depressive Disorder
London and Liverpool, UK
Short-acting psychedelic for depression
We are evaluating short acting psychedelics, like SPL026, with supportive therapy as a potential new approach to the treatment of depression.
“It needs to be competitive in public health systems; it needs to be kind of cost-effective. If a more condensed, powerful experience could have therapeutic effects... then it's totally worth exploring.” Dr David Erritzoe, Psychiatrist at Imperial College London
Partners
Anticipated treatment journey
Preparation
The therapist helps patients feel comfortable about the dosing experience, explore their life history, their intentions and ultimately help them build a patient-therapist relationship.
Dosing Session
The patient is supervised by the therapy team as the medicine is administered in a calm room. The patient is encouraged to lie down, listen to music and use eye shades to enhance the experience.
Integration
The therapist works with the individual to interpret and identify insights from the psychedelic experience with the goal of achieving meaningful long-term change.
Self Healing
Individuals are encouraged to use additional approaches to reflect and continue their healing outside of the clinic setting.
Psychedelic therapist training
Overview
To support our clinical programs, we run a training program for therapists to support the delivery of short-acting psychedelic therapy protocols, such as with our lead program SPL026.
Designed by experts
Our training program has been designed in collaboration with leading experts in psychedelic therapy methods and approaches.
Multi-method approach
Our program uses multiple methods including theory, experimental learning and observational work, ensuring therapists feel comfortable and empowered to deliver the protocol in a clinical trial setting.
Recruitment process
